DLA Piper, in conjunction with The Lawyer, is compiling a report on Digital Therapeutics, where we are now, what the future holds, the legislation and the science. We are interested in the thoughts of CEOs and senior leaders who are shaping the environment as well and the teams working within the subject.
The link to the survey is
It would be great if you could take part, you'll receive a copy of the report.
A digital therapeutic is an intervention based on software as the key ingredient, which has direct impact on a disease. This is what distinguishes this category from the broader term digital health. Jörg Land, CEO, Sonormed